Artificial Intelligence-Assisted Diagnostic Cytology and Genomic Testing for Hematologic Disorders

卷:12

Review

关键词: ADVANCED RBC APPLICATION;    PERFORMANCE EVALUATION;    DM96 SYSTEM;    CLASSIFICATION;    PREDICTION;    LYMPHOMA;    MODEL;    RED;   

DOI  :  10.3390/cells12131755

来源: SCIE

【 摘 要 】

Artificial intelligence (AI) is a rapidly evolving field of computer science that involves the development of computational programs that can mimic human intelligence. In particular, machine learning and deep learning models have enabled the identification and grouping of patterns within data, leading to the development of AI systems that have been applied in various areas of hematology, including digital pathology, alpha thalassemia patient screening, cytogenetics, immunophenotyping, and sequencing. These AI-assisted methods have shown promise in improving diagnostic accuracy and efficiency, identifying novel biomarkers, and predicting treatment outcomes. However, limitations such as limited databases, lack of validation and standardization, systematic errors, and bias prevent AI from completely replacing manual diagnosis in hematology. In addition, the processing of large amounts of patient data and personal information by AI poses potential data privacy issues, necessitating the development of regulations to evaluate AI systems and address ethical concerns in clinical AI systems. Nonetheless, with continued research and development, AI has the potential to revolutionize the field of hematology and improve patient outcomes. To fully realize this potential, however, the challenges facing AI in hematology must be addressed and overcome.